Screening for Disease

Screening Fundamentals - Spotting Trouble Early

• Definition: Active search for unrecognised disease/defect in apparently healthy individuals using tests, examinations, or procedures.
• Aim: Early detection & intervention to ↓ morbidity & mortality.
• Natural History of Disease:
  • Screening identifies disease in its preclinical phase.
  • Lead Time: Period between detection by screening & when it would have been diagnosed due to symptoms.
  • Detectable Pre-Clinical Phase (DPCP): Time interval during which the disease is detectable by screening.

⭐ Screening is a form of secondary prevention.

• Not diagnostic; positives require confirmation.
• Applied to groups, not individuals (unlike case finding).

Screening Strategies & Rules - Who, What, How?

• Screening Strategies (Who & How):
  • Mass Screening: Entire population/subgroups (e.g., newborn screening for hypothyroidism).
  • High-Risk (Selective) Screening: Targets individuals with specific exposures or ↑ risk factors (e.g., Pap smear for sexually active women). Higher yield.
  • Multiphasic Screening: Multiple tests concurrently to many (e.g., periodic health exams).
  • Opportunistic (Case-Finding) Screening: Testing patients consulting for unrelated reasons (e.g., routine BP check).

⭐ High-risk screening typically has higher Positive Predictive Value (PPV) than mass screening due to ↑ disease prevalence in the targeted group.

Evaluating Screening Tests - Numbers Don't Lie

• 2x2 Table: Basis for metrics.

  	Disease +	Disease -
  Test +	TP	FP
  Test -	FN	TN

• Sensitivity (Sn): True Positive Rate. $Sn = \frac{TP}{TP+FN}$
  • 📌 SNOUT: High Sn, Negative result, rules OUT.
• Specificity (Sp): True Negative Rate. $Sp = \frac{TN}{TN+FP}$
  • 📌 SPIN: High Sp, Positive result, rules IN.
• Positive Predictive Value (PPV): $PPV = \frac{TP}{TP+FP}$
• Negative Predictive Value (NPV): $NPV = \frac{TN}{TN+FN}$
• Accuracy: $\frac{TP+TN}{Total}$

⭐ PPV ↑ with prevalence; NPV ↓ with prevalence.

• Likelihood Ratio (+ve): $LR+ = \frac{Sn}{1-Sp}$ (Strong if >10)
• Likelihood Ratio (-ve): $LR- = \frac{1-Sn}{Sp}$ (Strong if <0.1)

Screening Pitfalls - Dodging Deception

Common biases distorting screening effectiveness:

• Lead-time bias: Apparent ↑ survival from early diagnosis, not delayed death.
• Length-time bias: Detects more slow-progressing, indolent cases.
• Volunteer bias: Healthier participants skew results positively.
• Overdiagnosis: Finding "disease" that won't cause harm.
• Compliance bias: Adherent individuals may have better health behaviors. 📌 Mnemonic for biases: Lazy Lions Vex Old Cats.

⭐ Lead-time bias creates an illusion of prolonged survival by advancing diagnosis time, without altering the actual outcome.

Screening in India - National Health Focus

• NPCDCS: NCD screening (hypertension, diabetes, oral/breast/cervical cancers) for ≥30 yrs, often via AB-HWCs.
• RCH Program: Antenatal screening (e.g., HIV, Syphilis, Anemia, GDM).
• RBSK: Children (0-18 yrs) screened for '4Ds' (Defects, Diseases, Deficiencies, Developmental delays).
• Anemia Mukt Bharat (AMB): Targets anemia reduction across life stages.

⭐ Under NPCDCS, women aged 30-65 years are recommended for cervical cancer screening every 5 years (e.g., VIA, VILI, Pap smear).

High‑Yield Points - ⚡ Biggest Takeaways

• Screening is presumptive identification of unrecognized disease; it's not diagnostic.
• A good test is valid (sensitive, specific), reliable, acceptable, and cost-effective.
• Sensitivity detects true positives (SNOUT); Specificity detects true negatives (SPIN).
• Lead Time Bias: Earlier detection gives apparent survival benefit, not improved prognosis.
• Length Time Bias: Screening finds more slow-growing cases, overestimating survival.
• PPV (Positive Predictive Value) is directly influenced by disease prevalence.
• Reliability (precision) ensures consistent results on repeat testing for a screening program's success.